Preemptive and Preventive Use of Paracetamol for Pain Relief After Cesarean Section
NCT ID: NCT02714179
Last Updated: 2016-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
54 participants
INTERVENTIONAL
2015-05-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preemptive Analgesia With Intravenous Paracetamol for Post-cesarean Section Pain Control
NCT02369133
Oral Self Medication Versus IV Administration of Pain Killers After Caesarian Delivery
NCT01566253
Intravenous Versus Oral Acetaminophen for Postoperative Pain Control After Cesarean Delivery
NCT02487303
Preoperative Cesarean Section Intravenous Acetaminophen and Postoperative Pain Control
NCT02694653
Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section
NCT02279628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Preemptive (Group PE),
Group I: i.V. paracetamol 1 g (100 ml) was given 30 min before induction of anesthesia.
Paracetamol was given intravenously in both group at different times
Group Preventive (Group PV),
Group II: i.V. paracetamol 1 g (100 ml) was given before the end of surgery.
Paracetamol was given intravenously in both group at different times
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paracetamol was given intravenously in both group at different times
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baskent University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ozlem Ozmete
Medical Doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA15/80
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.